Pharmaceutical / Drug Definition :
Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria. Exhibits minimal immunosuppressant activity.
In the United States, Ceftazidime Sodium is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Ceftazidime Sodium.
FDA Label Requirements and Exceptions
FDA Import Information
Ceftazidime Sodium (Ceftazidime Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Ceftazidime Sodium (Ceftazidime Sodium Suppliers)
- Processors Ceftazidime Sodium
- Repackers Ceftazidime Sodium
- Relabelers Ceftazidime Sodium
- Exporters Ceftazidime Sodium
- Importers Ceftazidime Sodium
For more information about Ceftazidime Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.